Appointment booking for coronavirus vaccination for persons who belong to risk group 1 opens
Appointment booking for coronavirus vaccinations for 18–69-year-olds who live in Soite’s area and belong to risk group 1 opens in the electronic Omahoito service on Friday 26th of February 2021 at 12 noon and on Soite’s phone line for appointment booking on Tuesday 2nd of March 2021. Persons who belong to risk groups will no longer be personally contacted about coronavirus vaccinations: instead, everyone has to book an appointment themselves.
You can book an appointment for a coronavirus vaccination either electronically or by phone:
- electronic appointment booking in the Omahoito service on the address: https://soite.terveytesi.fi, the service opens on Friday 26th of February 2021 at 12 noon. You have to log in to the Omahoito service with your own bank codes (or other secure identification) before you can book an appointment for yourself.
- appointment booking opens on Tuesday March 2nd at 12 o’clock at the number 06 828 7488. The phone booking will be open as long as there are appointments available. At other times, you will hear a recorded message.
The electronic appointment booking runs more smoothly and we recommend that you book your appointment online if possible.
Persons under the age of 18 (i.e. 16–18-year-olds) who belong to risk group 1 are vaccinated at the Children’s hospital (Lastensairaala/Barnsjukhuset).
Persons younger than 70 will be vaccinated using AstraZeneca’s vaccine. Persons who live in the same household as an at-risk person are not eligible for vaccination at this stage.
Be prepared to prove that you belong to a risk group
When you arrive at the vaccination site, be prepared to prove that you belong to a risk group (e.g. by showing your Kela card or a copy of your epicrisis or prescription). Group 1 consists of 16–69 year-olds with an illness or condition that is highly predisposing to severe coronavirus disease:
- Organ transplant or stem cell transplant
This group includes people who have received an organ transplant and people who have received a stem cell transplant no more than six months ago. The group also includes everyone who uses anti-rejection medication due to stem cell transplantation, regardless of the time of the stem cell transplantation.
Anti-rejection medication suppresses the immune system. According to international literature, use of anti-rejection medication multiplies the risk of severe COVID-19 disease.
- People undergoing active cancer treatment
The group includes those with a cancer that strongly impairs the function of the immune system. These include some types of leukaemia and lymphoma. The group also includes those whose cancer is treated in a way that strongly weakens their immune defence.
In addition, the group includes persons receiving a type of cancer therapy that impairs immune defence to reduce symptoms or to slow the cancer down. The group also includes those who have been getting a type of drug treatment that significantly weakens immune defence no more than 6 months earlier.
The group does not include persons whose cancer has been treated only surgically or who receive treatment that does not affect the immune defence. Such treatment includes adjuvant hormonal therapy for breast cancer.
Especially haematological cancers or blood cancers, such as leukaemias and lymphomas, increase the risk of severe disease because the cancer targets cells in the human body that protect against infection. In addition, cancer treatments often include medication that weakens the immune defence system.
- Severe disorders of the immune system
This group includes people with severe inherited immunodeficiency or lowered resistance due to another reason. In addition, the group includes HIV-positive persons with a CD4 helper cell level of less than 0.350 x 109 cells/l and persons who have had their spleen removed. The group also includes e.g. persons whose rare diseases affect immune defence.
In this risk group, the condition itself causes an abnormal immune response. The group does not include mild abnormalities common in general population, such as IgA deficiency, deficiency of mannose-binding lectin or partial deficiency of complement factor C4.
- Severe chronic renal disease
This group includes, for example, people with renal disease requiring dialysis, glomerular disease, renal damage related to hypertension or diabetes, or other chronic renal failure.
Severe renal failure is known to predispose to severe infections. On the other hand, COVID-19 infection can complicate chronic renal diseases. On the other hand, COVID-19 infection can complicate chronic renal diseases.
In studies of the risk of hospitalisation, admission to an intensive care unit or death, renal failure was almost without exception more common among patients with the most severe form of COVID-19.
- Severe chronic pulmonary disease
This group includes, for example, chronic obstructive pulmonary disease (COPD), pulmonary emphysema, bronchial dilatation, chronic bronchitis and cystic fibrosis.
The group also includes people with clearly decreased lung capacity (e.g. people with one lung) and people with asthma who have taken corticosteroid tablets by mouth during the past year.
People suffering from difficult-to-manage asthma are vaccinated in group 1 (People with an illness or condition that is highly predisposing to severe coronavirus disease) and other people suffering from asthma in group 2 (People with an illness or condition that is predisposing to severe coronavirus disease).
Chronic pulmonary diseases impair breathing capacity and can complicate the coronavirus disease. Also, COVID-19 infection can, in turn, further complicate the chronic pulmonary disease.
Use of cortisone tablets taken by mouth can be considered a sign of poorly controlled asthma.
- Type 2 diabetes with medication
This group includes type 2 diabetes requiring medication. High blood glucose is known to increase susceptibility to infection. In addition, acute infections impair the treatment of diabetes. Type 2 diabetes is often associated with obesity, which in turn also increases the risk of severe coronavirus disease.
- Down syndrome
This group includes people above 16 years of age with Down syndrome.
Down syndrome is associated with abnormalities of the immune system that manifest, for example, as susceptibility to infection. Also, COVID-19 infection can complicate problems caused by structural anomalies associated with the syndrome (e.g. congenital heart disease). Additional information at THL’s web site.